Professional
Added to YB: 2026-06-22
Pitch date: 2026-03-31
DIVISLAB.NS [bullish]
Divi's Laboratories Limited
Author Info
No bio for this author
Company Info
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
Market Cap
INR 1.8T
Pitch Price
N/A
Price Target
N/A
Dividend
0.44%
EV/EBITDA
51.03
P/E
69.70
EV/Sales
16.63
Sector
Life Sciences Tools and Services
Category
growth
Baron India Fund Added On Position: Divi's Laboratories Limited
DIVISLAB.NS (added to position): Leading global API/intermediates maker; key beneficiary of supply chain shift away from China. Onboarded by big pharma into GLP-1 value chain (peptides/intermediates), giving multi-year revenue visibility. Sees mid-teens rev CAGR, 20% EPS growth over 3-5 yrs.
Read full article (1 min)